| Remote Magnetic Navigation For Cavotricuspid Isthmus Ablation (NCT00560872) | University Hospital Goettingen | 2007-08-01 |
| Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation (NCT00412984) | Bristol-Myers Squibb | 2006-12-31 |
| Maximum Targeted Ablation of Atrial Flutter (NCT00491010) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2006-07-01 |
| Concentrations of Amiodarone in Fat Tissue During Chronic Treatment (NCT00313443) | Hopital Lariboisière | 2006-04-01 |
| Prevention of Atrial Tachycardia After a Right Atriotomy II (NCT00709384) | Aarhus University Hospital Skejby | 2006-01-01 |
| Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter (NCT00318565) | Biosense Webster, Inc. | 2006-01-01 |
| A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers (NCT00321945) | Emory University | 2005-12-01 |
| Routine Mini-invasive Electrophysiology Study for Patients Feeling Tachycardia, With a Negative Holter ECG (NCT00251121) | Sykehuset Telemark | 2005-11-01 |
| Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr (NCT00232310) | Sanofi | 2005-10-01 |
| Markers of Oxidative Stress Present in Blood in Patients With Atrial Fibrillation (NCT00142194) | Emory University | 2005-06-01 |
| A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation (NCT00174785) | Sanofi | 2005-06-01 |
| Markers of Oxidative Stress Present in Left Atrial Appendage Tissue in Patients With Atrial Fibrillation (NCT00243802) | Emory University | 2005-05-01 |
| Antero-posterior Versus Antero-lateral Electrode Position for Electrical Cardioversion of Typical Atrial Flutter (NCT00860314) | Universitätsklinikum Hamburg-Eppendorf | 2005-01-01 |
| Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter (NCT00233441) | Sanofi | 2004-12-01 |
| Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects (NCT00126022) | Solvay Pharmaceuticals | 2004-12-01 |
| Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects (NCT00126061) | Solvay Pharmaceuticals | 2004-10-01 |
| Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects (NCT00126074) | Solvay Pharmaceuticals | 2004-10-01 |
| Safety and Efficacy Study of RENEWAL 4 AVT (NCT00180336) | Boston Scientific Corporation | 2004-07-01 |
| Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8) (NCT00326001) | Biotronik SE & Co. KG | 2004-06-01 |
| Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter (NCT00115791) | Astellas Pharma Inc | 2004-06-01 |
| Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery (NCT00125320) | Astellas Pharma Inc | 2004-06-01 |
| Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter (NCT00113178) | Boston Scientific Corporation | 2004-01-01 |
| Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia (NCT00232232) | Melbourne Health | 2003-09-01 |
| A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter (NCT00476112) | Advanz Pharma | 2003-08-01 |
| Randomized Study of Radiofrequency- vs. Cryo-Ablation for Typical Isthmus-Dependent Atrial Flutter (NCT00196170) | Deutsches Herzzentrum Muenchen | 2003-05-01 |
| EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS) (NCT00259428) | Sanofi | 2001-11-01 |
| American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm (NCT00259376) | Sanofi | 2001-11-01 |
| Catheter Ablation as the First Line Therapy for Typical Atrial Flutter (NCT00213408) | University Hospital, Rouen | 2001-06-01 |